| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 239.00K | — |
| Operating expense | — | — |
| Net income | -11.26M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, IMDX returned +66.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -42.4% |
| 1 year | +66.8% |
| 5 years | -94.7% |
| 10 years | -94.4% |
| All-time high | $151.00 (Sep 2017) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in IMDX would be worth today ›No. Insight Molecular Diagnostics Inc. has not paid a dividend in the past 12 months.
Insight Molecular Diagnostics Inc. stock trades on NASDAQ under the ticker symbol IMDX.
Insight Molecular Diagnostics Inc. is part of the Healthcare sector.
Insight Molecular Diagnostics Inc. has a market cap of 141.37M USD, based on the latest quote.
Insight Molecular Diagnostics Inc. is expected to report earnings around Nov 9, 2026. That date is an estimate and has not been confirmed by the company.
